Cargando…
Targeting Aldehyde Dehydrogenases to Eliminate Cancer Stem Cells in Gynecologic Malignancies
Gynecologic cancers cause over 600,000 deaths annually in women worldwide. The development of chemoresistance after initial rounds of chemotherapy contributes to tumor relapse and death due to gynecologic malignancies. In this regard, cancer stem cells (CSCs), a subpopulation of stem cells with the...
Autores principales: | Muralikrishnan, Vaishnavi, Hurley, Thomas D., Nephew, Kenneth P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225959/ https://www.ncbi.nlm.nih.gov/pubmed/32295073 http://dx.doi.org/10.3390/cancers12040961 |
Ejemplares similares
-
Alcohol dehydrogenase and aldehyde dehydrogenase in malignant neoplasms
por: Orywal, Karolina, et al.
Publicado: (2016) -
A Novel ALDH1A1 Inhibitor Blocks Platinum-Induced Senescence and Stemness in Ovarian Cancer
por: Muralikrishnan, Vaishnavi, et al.
Publicado: (2022) -
Reduced aldehyde dehydrogenase expression in preeclamptic decidual mesenchymal stem/stromal cells is restored by aldehyde dehydrogenase agonists
por: Kusuma, Gina D., et al.
Publicado: (2017) -
Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC
por: MacDonagh, Lauren, et al.
Publicado: (2017) -
Targeting aldehyde dehydrogenase for prostate cancer therapies
por: Ma, Miao, et al.
Publicado: (2022)